share_log
Reuters ·  Mar 7 21:58
Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment